BioCryst Pharmaceuticals | Passivo Circulante

Preço das Ações
6.55
Mudança Diária
0.25 3.97%
Mensal
-7.62%
Anual
-27.14%
Q1 Previsão
4.65




Passivo Circulante Alterar Data
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
Chugai Pharma JPY 411.08B 143.65B 2025-12
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
DBV Technologies USD 49.48M 60K 2025-09
Enanta Pharmaceuticals USD 48.56M 4.01M 2025-09
Gilead Sciences USD 12.3B 1.11B 2025-09
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Neurocrine Biosciences USD 638M 91.7M 2025-09
Novavax USD 429.87M 40.73M 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 4.48B 336.9M 2025-09


BioCryst Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.